Cardiff Oncology, Inc.
CRDF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $51 | $22 | $16 | $12 |
| Short-Term Investments | $40 | $53 | $89 | $129 |
| Receivables | $1 | $0 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $2 | $5 | $5 |
| Total Curr. Assets | $95 | $77 | $111 | $146 |
| Property Plant & Equip (Net) | $2 | $3 | $4 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $1 | $0 |
| Total NC Assets | $2 | $4 | $5 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $97 | $82 | $116 | $150 |
| Liabilities | – | – | – | – |
| Payables | $5 | $2 | $2 | $1 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $8 | $5 | $5 |
| Total Curr. Liab. | $13 | $10 | $8 | $7 |
| LT Debt | $1 | $1 | $2 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $1 | $2 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $3 | $3 |
| Total Liabilities | $14 | $12 | $10 | $9 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$384 | -$340 | -$298 | -$260 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $467 | $409 | $405 | $400 |
| Total Equity | $83 | $70 | $106 | $140 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $97 | $82 | $116 | $150 |
| Net Debt | -$50 | -$20 | -$14 | -$9 |